This wiki has undergone a migration to Confluence found Here
Difference between revisions of "20170110 US Realm SC Call"
Jump to navigation
Jump to search
| Line 76: | Line 76: | ||
*Review notes from [[20161206_US_Realm_SC_Call]] | *Review notes from [[20161206_US_Realm_SC_Call]] | ||
*Review Items: | *Review Items: | ||
| − | **Newborn Dried Blood Spot Screening Lab Order Component/ Implementation Guide | + | **[http://gforge.hl7.org/gf/download/trackeritem/12571/15022/HL7%20Project%20Scope%20Statement%20v2016_OO_LOI_NDBS_20161222.docx Project Approval Request] from the OO WG of the SSD-SD of ''Newborn Dried Blood Spot Screening Lab Order Component/ Implementation Guide'' |
*Discussion: | *Discussion: | ||
**Do we want to expand the scope of the FHIR US-Core? What is the process? | **Do we want to expand the scope of the FHIR US-Core? What is the process? | ||
| Line 124: | Line 124: | ||
| − | © | + | © 2017 Health Level Seven® International. All rights reserved |
Revision as of 14:57, 10 January 2017
back to US_Realm_Steering_Committee
back to US_Realm_Steering_Committee_Conference_Calls
| US Realm Steering Committee Call Agenda/Minutes Location: call 770-657-9270 using code 156896# |
Date: 2017-01-10 Time: 1 PM Eastern | ||
| Co-Chairs | Ed/Brett | Note taker(s) | Anne |
| Attendee / Name | |||||||||||
| Calvin Beebe | Keith Boone | Hans Buitendijk | |||||||||
| Lorraine Constable | Johnathan Coleman | Ed Hammond | |||||||||
| Tony Julian | Paul Knapp | Austin Kreisler | |||||||||
| Brett Marquard | Ken McCaslin | Nancy Orvis | |||||||||
| Brian Pech | Wayne Kubick | Mark Roche | |||||||||
| Sandra Stuart | . | Pat Van Dyke | . | Anne Wizauer | |||||||
| Danielle Friend | . | Eric Haas | . | Jenni Syed | |||||||
| Steve Posnak | . | David Susanto | . | Visitor / Name | |||||||
| no quorum definition | |||||||||||
Agenda
Administrivia
- Agenda review
- Review notes from 20161206_US_Realm_SC_Call
- Review Items:
- Project Approval Request from the OO WG of the SSD-SD of Newborn Dried Blood Spot Screening Lab Order Component/ Implementation Guide
- Discussion:
- Do we want to expand the scope of the FHIR US-Core? What is the process?
- What US Realm FHIR IGs are we tracking? (this should probably be a recurring agenda item)
- Who is providing coordination among those IGs?
- Do we want to develop a list of principles for developing US Realm FHIR IGs?
- Reuse us-core
- Follow us realm extension development process
- Quality criteria (see example SDWG use for C-CDA)
Minutes
Meeting Outcomes
| Actions
|
Next Meeting/Preliminary Agenda Items
|
© 2017 Health Level Seven® International. All rights reserved
